On Friday, Zomedica Corp (AMEX: ZOM) was -5.21% drop from the session before settling in for the closing price of $0.14. A 52-week range for ZOM has been $0.12 – $0.20.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 97.76% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at -37.14%. With a float of $962.66 million, this company’s outstanding shares have now reached $979.95 million.
In an organization with 144 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 55.24%, operating margin of -143.14%, and the pretax margin is -232.24%.
Zomedica Corp (ZOM) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Zomedica Corp stocks. The insider ownership of Zomedica Corp is 1.76%, while institutional ownership is 8.26%. The most recent insider transaction that took place on Nov 08 ’24, was worth 18,450. In this transaction COO of this company bought 150,000 shares at a rate of $0.12, taking the stock ownership to the 400,000 shares. Before that another transaction happened on Nov 11 ’24, when Company’s Director bought 100,000 for $0.12, making the entire transaction worth $12,100. This insider now owns 2,425,000 shares in total.
Zomedica Corp (ZOM) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.01 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -37.14% per share during the next fiscal year.
Zomedica Corp (AMEX: ZOM) Trading Performance Indicators
You can see what Zomedica Corp (ZOM) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 10.15. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.80.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.06, a number that is poised to hit -0.01 in the next quarter and is forecasted to reach -0.03 in one year’s time.
Technical Analysis of Zomedica Corp (ZOM)
Let’s dig in a bit further. During the last 5-days, its volume was 12.83 million. That was inferior than the volume of 15.09 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 42.93%. Additionally, its Average True Range was 0.01.
During the past 100 days, Zomedica Corp’s (ZOM) raw stochastic average was set at 34.15%, which indicates a significant increase from 31.99% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 75.12% in the past 14 days, which was higher than the 50.50% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.1271, while its 200-day Moving Average is $0.1387. However, in the short run, Zomedica Corp’s stock first resistance to watch stands at $0.1359. Second resistance stands at $0.1408. The third major resistance level sits at $0.1437. If the price goes on to break the first support level at $0.1281, it is likely to go to the next support level at $0.1252. Assuming the price breaks the second support level, the third support level stands at $0.1203.
Zomedica Corp (AMEX: ZOM) Key Stats
There are 979,950K outstanding shares of the company, which has a market capitalization of 128.37 million. As of now, sales total 25,190 K while income totals -34,530 K. Its latest quarter income was 7,000 K while its last quarter net income were -6,700 K.
